Menu

FAQ Directory

Here are some of the most frequently asked questions about NCQA’s various programs. If you don’t see what you are looking for in one of the entries below, you can  ask a question through My NCQA.

Filter Results
  • Save

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

  • Email

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

  • Print

    Print this page.

    Print this page.

expand all

6.15.2013 Practitioner involvement in the QI Committee for Interim Surveys Other than review and approveal of policies and procedures, what is expected to meet the requirement of practitioner involvement?

The organization must provide evidence that practitioners were involved in review and approval of policies and procedures.

6.15.2013 Distribution of materials for Interim Surveys Where elements require materials as a data source for all survey types, must the materials be distribute for Interim Surveys?

Organizations going through Interim Survey must present materials to meet the requirements of the element. Materials are not required to have been distributed, and do not have to be in final layout form, but must be approved by the organization. Draft materials are appropriate if approved by the organization.

6.15.2013 Look-back period for Exchange products coming through Renewal Survey What is the look-back period for Exchange products coming through a Renewal Survey (i.e. concurrently with an existing NCQA Accredited product)?

The look-back period is prior to the survey date for the Exchange product line.

6.15.2013 Documentation for Interim Surveys for interpreter services What is the required documentation for interpreter or bilingual services since there may be no membership? What is required as evidence?

The organization must provide a documented process describing how it plans to meet the requirements when it does have a membership with a need for such services.

6.15.2013 Medical record review requirement for Exchanges in Florida and Pennsylvania Is a medical record review required for Exchanges coming through Interim Survey in Florida or Pennsylvania?

No. Because Exchanges come under federal statutes, and medical record review is not required at this time under the federal statutes, medical record review is not included in Interim Surveys in Florida and Pennsylvania.

5.16.2013 General Guidelines Does an ICD-9 code of "411" mean that only code "411" is to be used, or do we also include all successor codes: 411.0, 411.1, 411.81, 411.89?

Unless otherwise noted, codes are stated in the minimum specificity required. For example, if a three-digit code is listed, it is valid as a three-, four- or five-digit code. If a table lists ICD-9-CM Diagnosis code 401, the codes 401.0, 401.1 and 401.9 are acceptable for P4P reporting. When required, a code will be specified with an x, which represents a valid digit that must be used for reporting. For example, ICD-9-CM diagnosis code 640.x1 indicates that any valid fourth digit can be used if the fifth digit is 1.

5.15.2013 Pay-for-performance Program If our organization displays information about our pay-for-performance program but does not display physician performance information for this program, how does NCQA score PQ 3A, 3B, 3C, 3D and 4B?

PQ 3A factors 3-5 and PQ 3B are scored NA if the organization does not display physician performance information for the pay-for-performance program.

PQ 3 C and D are scored against the pay-for-performance requirements if the organization has one complaint process for all programs. If the organizations complaint process is program-specific, PQ 3C and D are scored NA for the pay-for-performance program. NCQA scores PQ 4B factor 1 and the customer portion of factor 4 NA for the pay-for-performance program.

Because there is no NA scoring option in PQ 3B, 3C and 4B, these requirements are scored yes for pay-for-performance programs described above until the NA scoring option is added during the 7/29 release of the ISS tool.

PHQ 2013

5.15.2013 When ER files are included in the universe of files for review When are ER denial files included in the universe of files for file review during an Accreditation or Certification Survey?

Generally, ER denials are not included in the universe of files for initial UM decisions unless a denial is appealed. In that case, the ER appeal is included in the universe of files for appeals.

UM-CR 2013

5.15.2013 Monitoring Medicare Opt-Out Physicians May MA organizations use NPDB-HIPDB as a source of information for Medicare opt-out physicians?

No. The NPDB-HIPDB may not be used as a source for verifying a practitioner's status in relation to the Medicare Opt-Out Program. MA organizations can check with their states' Medicare Opt-Out list.

MA 2013

5.15.2013 National Student Clearinghouse as a source for education and training Does NCQA accept the National Student Clearinghouse (NSC) as a source for education and training?

The NSC is not recognized by NCQA as a source for education and training. However, the NSC would be considered an agent of the medical or professional school if the school has a contract with the Clearinghouse to provide verification services. The organization must provide documentation that the specific school has a contract with the Clearinghouse.

UM-CR 2013

4.16.2013 Diabetes Care (CDC) The following note appears to be listed under the Optimal Diabetes Care indicator for CDC: Additional exclusion criteria are required for this indicate that will results in a different eligible population from all other indicators. What are the additional criteria for the Optimal Diabetes Care indicator?

This footnote is meant to refer to the HbA1c<7% indicator; HbA1c<7% is the only CDC indicator that has a different eligible population from the other indicators. The footnote will be correctly placed in the MY2013 P4P Manual.

4.16.2013 Asthma Medication Ration (AMR) Table AMR-C includes the drug Indacteral, but this drug is not the final ASM-C NDC table. Should Indacteral be included in the measure?

No. Indacteral was removed from the ASM-C NDC list and noted in a Word document posted with the NDC lists on November 2, 2012. The medication was reviewed by the HEDIS Expert Pharmacy Panel and determined to be not indicated for asthma, so it was removed from the measure. The MY 2013 P4P manual will reflect this change.